Novel Antibody-Drug Conjugate to Treat HER2-positive Metastatic Breast Cancer
Breast cancer is the most common cancer in women in the U.S., and HER2-positive breast cancer (HER2+ BC) accounts for 15-20% of all breast cancer diagnoses. HER2+ breast cancer is…